stockportfolio.pro
Harmony Biosciences Holdings, Inc. Total Debt 2019–2025
Harmony Biosciences Holdings, Inc. (HRMY) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings. Compound growth +8.9%/yr over 6 years.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $163.66M | -8.7% |
| FY 2024 | $179.27M | -7.4% |
| FY 2023 | $193.57M | +1.0% |
| FY 2022 | $191.65M | -0.2% |
| FY 2021 | $191.98M | -1.2% |
| FY 2020 | $194.25M | +98.3% |
| FY 2019 | $97.95M | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s total debt (short- plus long-term borrowings)?
Harmony Biosciences Holdings, Inc. (HRMY) reported total debt (short- plus long-term borrowings) of $163.66M for fiscal year 2025, per its SEC filings.
How has Harmony Biosciences Holdings, Inc.'s total debt (short- plus long-term borrowings) changed over time?
Between fiscal 2019 and 2025, HRMY's total debt (short- plus long-term borrowings) grew at roughly 8.9% per year (compound annual rate), from $97.95M to $163.66M.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.